Search

Search Constraints

You searched for: Author/Creator Logothetis, Christopher J.

Search Results

2. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable‐risk prostate cancer undergoing active surveillance. (4th July 2015)

3. Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable‐risk prostate cancer undergoing active surveillance. (21st April 2015)

4. Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort. (2nd January 2019)

5. Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer. (November 2021)

6. Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort. Issue 5 (10th November 2021)

7. Reply by Authors. Issue 5 (10th November 2021)

8. A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer. (March 2020)

9. Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302. (July 2022)